{"ticker": {"uuid": "00700292-dd28-460b-a143-b9eb0764c26a", "symbol": "RTW", "name": "RTW Biotech Opportunities Ltd", "exchange": "LSE", "country": "GB", "sector": "Financial Services", "industry": "Asset Management"}, "articles": [{"title": "RTW Biotech Opportunities reports 9.7% June NAV increase", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPNnV0U0tmd0JqQ1Z6SDgtdjQ0TEFyMkNnVDVLWXY4TF8xckxmWmN2dW1Fd3VlVVNyOTJmMmpPdGFydU9zamNnOWMydEhDeWo1eklzeGJNMzdod09aT2RiaFF6WmZwUWtaSkNMLWJoc2FsN1lqYlQ0YVN5Tkd0TmpxdlBRVFVwV0g5emIxZHY3Y201ZUdQdTBwZkU3cTVvaFhjQ3NabmxPYWthMnFqQVU5VVJZcjFKWDF6ZC1HWEZGSzUwamhQWmc?oc=5", "source_name": "Investing.com UK", "published_at": "2026-07-15T07:33:28+00:00", "published_display": "15 Jul 2026 07:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - RTW Biotech Opp. - Monthly Valuation Update and Factsheet", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxNdm5qa3VKVlpBbXRvaVg3Yk5aQ21xbTk0N055MEoyN2d5TnhpZ1ZpbFlJZFYwOUp4ZDQ4SmxnajM0aXo5YVc2dkJZS1A0T3NnNzZFV3V1b3A4YXJUSmxHU3ZjcFh3OWhiNFlkVklzaDNhMzM5VVJIUVRpaWswY2lJbFJIX1Z5MkNZV1BJQi1WZGZzZ1BlYlhHdVJ2QUM3R3M0cmNIaklUN0xwd0pxUVdQenJUb2ZOelFrUzhFYXp3U2U4MTM0UDVXckVxQm56TUE?oc=5", "source_name": "TradingView", "published_at": "2026-07-15T06:00:00+00:00", "published_display": "15 Jul 2026 06:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of RTW Biotech Opportunities Ltd USD \u2013 SWB:0BM", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQNDEzdHRsTUltcVRxam14T1BNbmNEbTZ4S0JfUmJwNzdzLXc0blRHR1VNRGttOHVIWk9kRU5rRWxNeWtqU1FEeFhiRGVYdUs3UU5WaklmaHVjMkNRUGJRWE84Y1N5TXlDRDdGSEZFWWRtWDFRYU1vLWMzZ2hobm5GVVFHUHJYQXBqRWJOQVFpeDd5QzhjVi1ZZHRMRmZ3MGJFcFFTZ293c2Y?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T00:49:17+00:00", "published_display": "11 Jul 2026 00:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - RTW Biotech Opp. - Additional investment in Lycia Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNMXR5VEl2d2dobGdsSi1ocUFEUUxtaGlHNmlqWlRobXRlam42d09BY1JYc1BpQXRRMGU0UUdBTUlJY1cwQUdrdU1hc3BlTnc3VDE0ZVh0bnN4c0UtSkMwT0hmMWZWazY3RlNGaDF1S3FuVGtUVGFmVVZhT3lQTFBaZWdxUU42WlhNUFRNVnBlVUl3cVlSTndVTjN0VEZqcHdrdVhpbFNvdEFOelZDb1pKU2VNOVB2MnNPLTVEa2Q4cjhHWEI0WURzMEk5MElvS05xeWY4cU9n?oc=5", "source_name": "TradingView", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Biotech Opportunities reports May NAV of $2.61 per share By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeUk5ZVFpdG1WYzdnOWI2QjY3ZHk4azc4UDU0TThBRkd4VE5XM1hDRENjOS0wUlJRbTRSdmRVMVpMN3FoUWJuOElpcE1kUk5YMWp6c2s3VjRCUHB1UHVWSklsemZyOHVJOXA5SFpoeHpfWVlzWFVTMnRoZnZLUEppSUFZWmdDeU5IaDVjMDJVV21GRko3MHpWLXpJcEt2OGNwTlFJYU9yQWhxNU5YZV9GWDJJWk5JYTRQb0JJ?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-12T07:00:46+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Biotech Delivers 92% 1-year Share Growth As Biotech Sentiment Improves", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQaFVnVHA1NmxLR25DNS1nRXBTS0N5bHdweVU1UnJBbHdvbjFUNDJnS3NTa0NsbW9icXFReFRGRUo0Nm0tTXFuMU5zZkttQ2hzVnBTZ1JiTnh5TmhrMWtLSGQtUTZjX1duU1M1RGxYSUlxRWZGUEJaZjY3VFZNSHF4eFp2cEpzNkdUbUZOM2hZSzZ3c2xmcWJ4c2x6Z2tpbW56a0RvZU4xODBEQQ?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-12T06:50:27+00:00", "published_display": "12 Jun 2026 06:50", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solid US earnings growth points to a wider group of opportunities", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOUXpZZU81Y0k4ZXRvTWhac3Vobm50NlExdXpYeHlxT2Vuc0RnNXgxdEhDclRLRTRieVQxY3JOOWE2d3Nwa3k4dm9Ib29EajFVMUIyeWRad3ZUd2NkbGNBd29BbkZfUVF4bGdFT2dKeWpEeFBFbVBCRE5rSzBsZld6bXpzQVVDLVJzNVYzMnRB?oc=5", "source_name": "UBS", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Bio Portfolio Company Kailera Raises $625m In Record Biotech IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQemdIdFhjdWlSMWt1YzE0a0dCWU15M09FWEg2QXI2andVMWpkam9aNVFQTXFaRzVfUTBfU240RVJXQnNmNy1PSkpjVm9HZ0hxTzVDVnRQOC1TVks0Vld5WEhnR3I0VFF3V3lPeG83cllVb0hGd1huc01KZlYyQzI5X0xXeTg4SFJkRUJZT2pGTEZwZVh6d2FKaHNwejZiMzZhRk44ZUh2Qi1faXdVTmJuYm9ESFFDXzUyc0E?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-04-20T06:34:47+00:00", "published_display": "20 Apr 2026 06:34", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Biotech says prospects are \"compelling\" as drug developers begin \u201ca new phase of maturity\u201d", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQelIwRFNSRmtCd0wzUXhPdy14cXhIWUVrVndpVU1hUWRtOENxYWVONUZ2NThyUno1bDVZbGxQdnZEaFlGSXNsalg3MzFnNGtHWndVdks4czVwZlVPVmNuRVl2UDJjLWxQWlFwYWEwV1dINDVuWGVTdUNnZkNEdmxxeFFPQTFvR2tZR1dkOUpnRm82WjBvN0JSVXJMZ2w2cF9HejM4b2NMdkY3MWxtRnhqb1EwR1RMQ2pGVzRxOWtHbw?oc=5", "source_name": "QuotedData", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Stock Fund Price and Chart \u2014 LSE:RTW", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE80cUpyTmc1XzE3WWotbE1kOFl4aThid1BHUm1QemFSWlZIaXJEVHFqT0YtTzFOR1NVRXJraWRmMTRad3NVZ1lKT3M3cGo4MkFjcU5aMGFtaw?oc=5", "source_name": "TradingView", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can the UK become a biotech superpower?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNa1pkLUVtY0tnY1ZHOUlLc0labzFOVEpEMG1kS3ROTTBpTktNdlA4VEg1T1VIckh5c1VsUkhJd0JaLVJkWnR0aG96QzZFM3RPaDZPWTMtOXNNS3B5REZYR1JrbHRqLTlxVEpHSkZ3MlFXLVM3eU1qZ3VWU0RRMVpyTUF6LVF2OEtS?oc=5", "source_name": "Investors' Chronicle", "published_at": "2023-12-14T08:00:00+00:00", "published_display": "14 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Biotech Opportunities (RTW) Share Price, Stock Value, News & Analysis $RTW", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE9qRzdWN1JhUVVScUo2d3FUbEtlMTdYVUFRY08tZGVnTngybjhTekdtcmRyYWVNWm9tTU1aX2QzSFRDU2JIR0F6QVRsc2VSa3BXVGxZVA?oc=5", "source_name": "MarketBeat", "published_at": "2020-12-24T16:53:28+00:00", "published_display": "24 Dec 2020 16:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "RTW Biotech Opportunities reports 9.7% June NAV increase", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPNnV0U0tmd0JqQ1Z6SDgtdjQ0TEFyMkNnVDVLWXY4TF8xckxmWmN2dW1Fd3VlVVNyOTJmMmpPdGFydU9zamNnOWMydEhDeWo1eklzeGJNMzdod09aT2RiaFF6WmZwUWtaSkNMLWJoc2FsN1lqYlQ0YVN5Tkd0TmpxdlBRVFVwV0g5emIxZHY3Y201ZUdQdTBwZkU3cTVvaFhjQ3NabmxPYWthMnFqQVU5VVJZcjFKWDF6ZC1HWEZGSzUwamhQWmc?oc=5", "source_name": "Investing.com UK", "published_at": "2026-07-15T07:33:28+00:00", "published_display": "15 Jul 2026 07:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - RTW Biotech Opp. - Monthly Valuation Update and Factsheet", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxNdm5qa3VKVlpBbXRvaVg3Yk5aQ21xbTk0N055MEoyN2d5TnhpZ1ZpbFlJZFYwOUp4ZDQ4SmxnajM0aXo5YVc2dkJZS1A0T3NnNzZFV3V1b3A4YXJUSmxHU3ZjcFh3OWhiNFlkVklzaDNhMzM5VVJIUVRpaWswY2lJbFJIX1Z5MkNZV1BJQi1WZGZzZ1BlYlhHdVJ2QUM3R3M0cmNIaklUN0xwd0pxUVdQenJUb2ZOelFrUzhFYXp3U2U4MTM0UDVXckVxQm56TUE?oc=5", "source_name": "TradingView", "published_at": "2026-07-15T06:00:00+00:00", "published_display": "15 Jul 2026 06:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of RTW Biotech Opportunities Ltd USD \u2013 SWB:0BM", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQNDEzdHRsTUltcVRxam14T1BNbmNEbTZ4S0JfUmJwNzdzLXc0blRHR1VNRGttOHVIWk9kRU5rRWxNeWtqU1FEeFhiRGVYdUs3UU5WaklmaHVjMkNRUGJRWE84Y1N5TXlDRDdGSEZFWWRtWDFRYU1vLWMzZ2hobm5GVVFHUHJYQXBqRWJOQVFpeDd5QzhjVi1ZZHRMRmZ3MGJFcFFTZ293c2Y?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T00:49:17+00:00", "published_display": "11 Jul 2026 00:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - RTW Biotech Opp. - Additional investment in Lycia Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNMXR5VEl2d2dobGdsSi1ocUFEUUxtaGlHNmlqWlRobXRlam42d09BY1JYc1BpQXRRMGU0UUdBTUlJY1cwQUdrdU1hc3BlTnc3VDE0ZVh0bnN4c0UtSkMwT0hmMWZWazY3RlNGaDF1S3FuVGtUVGFmVVZhT3lQTFBaZWdxUU42WlhNUFRNVnBlVUl3cVlSTndVTjN0VEZqcHdrdVhpbFNvdEFOelZDb1pKU2VNOVB2MnNPLTVEa2Q4cjhHWEI0WURzMEk5MElvS05xeWY4cU9n?oc=5", "source_name": "TradingView", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Biotech Opportunities reports May NAV of $2.61 per share By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeUk5ZVFpdG1WYzdnOWI2QjY3ZHk4azc4UDU0TThBRkd4VE5XM1hDRENjOS0wUlJRbTRSdmRVMVpMN3FoUWJuOElpcE1kUk5YMWp6c2s3VjRCUHB1UHVWSklsemZyOHVJOXA5SFpoeHpfWVlzWFVTMnRoZnZLUEppSUFZWmdDeU5IaDVjMDJVV21GRko3MHpWLXpJcEt2OGNwTlFJYU9yQWhxNU5YZV9GWDJJWk5JYTRQb0JJ?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-12T07:00:46+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Biotech Delivers 92% 1-year Share Growth As Biotech Sentiment Improves", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQaFVnVHA1NmxLR25DNS1nRXBTS0N5bHdweVU1UnJBbHdvbjFUNDJnS3NTa0NsbW9icXFReFRGRUo0Nm0tTXFuMU5zZkttQ2hzVnBTZ1JiTnh5TmhrMWtLSGQtUTZjX1duU1M1RGxYSUlxRWZGUEJaZjY3VFZNSHF4eFp2cEpzNkdUbUZOM2hZSzZ3c2xmcWJ4c2x6Z2tpbW56a0RvZU4xODBEQQ?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-12T06:50:27+00:00", "published_display": "12 Jun 2026 06:50", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solid US earnings growth points to a wider group of opportunities", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOUXpZZU81Y0k4ZXRvTWhac3Vobm50NlExdXpYeHlxT2Vuc0RnNXgxdEhDclRLRTRieVQxY3JOOWE2d3Nwa3k4dm9Ib29EajFVMUIyeWRad3ZUd2NkbGNBd29BbkZfUVF4bGdFT2dKeWpEeFBFbVBCRE5rSzBsZld6bXpzQVVDLVJzNVYzMnRB?oc=5", "source_name": "UBS", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Bio Portfolio Company Kailera Raises $625m In Record Biotech IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQemdIdFhjdWlSMWt1YzE0a0dCWU15M09FWEg2QXI2andVMWpkam9aNVFQTXFaRzVfUTBfU240RVJXQnNmNy1PSkpjVm9HZ0hxTzVDVnRQOC1TVks0Vld5WEhnR3I0VFF3V3lPeG83cllVb0hGd1huc01KZlYyQzI5X0xXeTg4SFJkRUJZT2pGTEZwZVh6d2FKaHNwejZiMzZhRk44ZUh2Qi1faXdVTmJuYm9ESFFDXzUyc0E?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-04-20T06:34:47+00:00", "published_display": "20 Apr 2026 06:34", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Biotech says prospects are \"compelling\" as drug developers begin \u201ca new phase of maturity\u201d", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQelIwRFNSRmtCd0wzUXhPdy14cXhIWUVrVndpVU1hUWRtOENxYWVONUZ2NThyUno1bDVZbGxQdnZEaFlGSXNsalg3MzFnNGtHWndVdks4czVwZlVPVmNuRVl2UDJjLWxQWlFwYWEwV1dINDVuWGVTdUNnZkNEdmxxeFFPQTFvR2tZR1dkOUpnRm82WjBvN0JSVXJMZ2w2cF9HejM4b2NMdkY3MWxtRnhqb1EwR1RMQ2pGVzRxOWtHbw?oc=5", "source_name": "QuotedData", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Stock Fund Price and Chart \u2014 LSE:RTW", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE80cUpyTmc1XzE3WWotbE1kOFl4aThid1BHUm1QemFSWlZIaXJEVHFqT0YtTzFOR1NVRXJraWRmMTRad3NVZ1lKT3M3cGo4MkFjcU5aMGFtaw?oc=5", "source_name": "TradingView", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can the UK become a biotech superpower?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNa1pkLUVtY0tnY1ZHOUlLc0labzFOVEpEMG1kS3ROTTBpTktNdlA4VEg1T1VIckh5c1VsUkhJd0JaLVJkWnR0aG96QzZFM3RPaDZPWTMtOXNNS3B5REZYR1JrbHRqLTlxVEpHSkZ3MlFXLVM3eU1qZ3VWU0RRMVpyTUF6LVF2OEtS?oc=5", "source_name": "Investors' Chronicle", "published_at": "2023-12-14T08:00:00+00:00", "published_display": "14 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Biotech Opportunities (RTW) Share Price, Stock Value, News & Analysis $RTW", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE9qRzdWN1JhUVVScUo2d3FUbEtlMTdYVUFRY08tZGVnTngybjhTekdtcmRyYWVNWm9tTU1aX2QzSFRDU2JIR0F6QVRsc2VSa3BXVGxZVA?oc=5", "source_name": "MarketBeat", "published_at": "2020-12-24T16:53:28+00:00", "published_display": "24 Dec 2020 16:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 74, "total_relevant": 12, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 9, "score": 54, "total": 12, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 92, "events": [{"event": "general", "label": "Market update", "weight": 6.05, "count": 11}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2.43, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": 10.0, "twelve_week_move": 9.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.872304, "market_dynamics_buy_signal": false, "relative_strength": 20.510551, "fair_value_gap": 58.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 55.2734, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +10.0% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 57, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 4}, {"label": "DirectorsTalk Interviews", "count": 2}, {"label": "Investing.com UK", "count": 1}, {"label": "Investing.com Canada", "count": 1}, {"label": "UBS", "count": 1}, {"label": "QuotedData", "count": 1}, {"label": "Investors' Chronicle", "count": 1}, {"label": "MarketBeat", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 12}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "92/100 classification confidence."}, {"label": "Company focus", "value": "12", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.0% over one week, +10.0% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "RTW Biotech Opportunities reports 9.7% June NAV increase"}], "updated_at": "2026-07-17T09:18:47.328474+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}